Effect of probiotics in children with asthma

Effect of probiotics on the standard regimen in clinical symptoms/signs and quality of life in children with asthma

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016021823046N2

Enrollment

147

Registered

2016-04-08

Start date

2016-04-08

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma. Asthma

Interventions

Intervention 1: Intervention group: Adding probiotics to standard treatment regimen of patients. Each treatment period includes 3 months. Drug dosage is one capsule daily. Intervention 2: Control grou

Treatment - Drugs

Placebo

Intervention group: Adding probiotics to standard treatment regimen of patients. Each treatment period includes 3 months. Drug dosage is one capsule daily.

Control group: adding placebo (placebo probiotics) to the standard treatment regimen of patients. Each treatment period includes 3 months. Drug dosage is one capsule daily.

Eligibility

Sex/Gender

All

Age

6 Years to 12 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age 6 to 12 years with asthma Exclusion criteria: viral or bacterial airway infections ; asthma uncontrolled ; use of antibiotics in the month before entering the study ; no drug

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Clinical signs asthma(cough, wheezing, dyspnea). Timepoint: Before intervention, the end of the first month, the end of second month, the end of the third month. Method of measurement: According to GINA questionnaire and Child ACT.;Quality of Life. Timepoint: Before intervention, the end of the first month, the second month, the end of the third month. Method of measurement: kINDL questionnaire.	—

Secondary

Measure	Time frame
Severe of Asthma. Timepoint: Before intervention, the end of the first month, the end of second month, the end of the third month. Method of measurement: According to need for treatment as recommended by GINA.;Score Of FEV1. Timepoint: Before intervention, the end of the first month, the second month, the end of the third month. Method of measurement: Spirometry.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehdi Gholamzadeh Baeis

Qom Branch Of Islamic Azad University

Dr.M.Gholamzadeh@Gmail.com+98 25 3280 8080

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026